Key Concepts in Identifying Drug Leads

April 24, 2014
Drug Discovery Series Part 3 of 8

Bottle of blue pills

How do you decide which leads to follow when developing new drugs? Join  Dr. Tudor Oprea and Dr. Christopher Lipinski (who formulated the Rule of Five) as they discuss how drug-likeness is a deceiving concept, explore the Rule of Five, and show how lessons from the past may guide the present. 

*Access to this recording is an exclusive benefit for ACS Members.

Benefits of Membership

  • ACS Webinars Archive: Every one of our 200+ past webinars available on demand
  • Save Money: Members receive discounts on meetings, development courses and more!
  • Access to SciFinder®: Members receive 25 complimentary SciFinder® research activities per year

The Fine Print

ACS Webinars® does not endorse any products or services. The views expressed in this presentation are those of the presenters and do not necessarily reflect the views or policies of the American Chemical Society.

ACS Webinars logo


Tudor Oprea
University of New Mexico

Chris Lipinski
Melior Discovery